| CCY | SZE(M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| USD | 1,100.000 | 5 | Mar-28 | Sr. Unsecured | A3 | A | - | Fixed | Tsy | T+95 a | T+75 | 75 | 4.88% | 0 | 99.79800 |
| USD | 650.000 | 7 | Mar-30 | Sr. Unsecured | A3 | A | - | Fixed | Tsy | T+105 a | T+90 | 90 | 4.90% | 5 | 99.59000 |
| USD | 500.000 | 10 | Mar-33 | Sr. Unsecured | A3 | A | - | Fixed | Tsy | T+115 a | T+100 | 100 | 4.88% | 5 | 99.72600 |
Tranche Comments
5 yr: Book size: 1800; First Pay: 2023-09-03; Redemption: 2028-02-03; Registration: Registered; Comments: US$1.1bn 4.875% cpn 5yr (3/3/28) at 99.798, yld 4.921%. Spread: T+75bp. MWC T+15bp. Par Call: 1m;
7 yr: Book size: 1300; First Pay: 2023-09-03; Redemption: 2030-01-03; Registration: Registered; Comments: US$650m 4.90% cpn 7yr (3/3/30) at 99.59 , yld 4 .907%. Spread: T+90bp. MWC T+15bp. Par Call: 2m;
10 yr: Book size: 1100; First Pay: 2023-09-03; Redemption: 2032-12-03; Registration: Registered; Comments: US$500m 4.875% cpn 10yr (3/3/33) at 99.726, yld 4.91%. Spread: T+100bp. MWC T+15bp. Par Call: 3m;
Guarantor(s)
AstraZeneca PLC
Use of Proceeds
Refinancing and general corporate purposes